SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-063823
Filing Date
2021-03-01
Accepted
2021-03-01 17:16:03
Documents
16
Period of Report
2021-03-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d136427d8k.htm   iXBRL 8-K 33410
2 EX-10.1 d136427dex101.htm EX-10.1 14499
3 EX-10.2 d136427dex102.htm EX-10.2 27760
4 EX-99.1 d136427dex991.htm EX-99.1 5846
8 GRAPHIC g136427img01.jpg GRAPHIC 10284
  Complete submission text file 0001193125-21-063823.txt   235311

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cort-20210301.xsd EX-101.SCH 3065
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20210301_lab.xml EX-101.LAB 17372
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20210301_pre.xml EX-101.PRE 10949
9 EXTRACTED XBRL INSTANCE DOCUMENT d136427d8k_htm.xml XML 3279
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 21699322
SIC: 2834 Pharmaceutical Preparations